Why is Arkema stock climbing today?

Arkema stock rose 2.3% after the French specialty chemicals group published third-quarter 2026 results that came in ahead of consensus expectations and accompanied by a reaffirmed annual outlook.

The company reported adjusted EBITDA of €332 million for the quarter, surpassing the analyst estimate of approximately €328 million, while group sales reached €2.36 billion on the back of 6.6% organic growth, with pricing contributing 6.0% and volumes adding a modest 0.6%.

Alongside the earnings beat, Arkema confirmed that full-year 2026 EBITDA would be slightly higher than the prior year at constant currencies, and reiterated a capital expenditure target of under €600 million.

CEO Thierry Le Hénaff noted that the company would continue concentrating on elements within its control amid a challenging external environment, with year-to-date cost savings of €55 million keeping the group on track to offset fixed-cost inflation for the full year.

Jefferies, however, maintained a hold rating, questioning whether the modest beat was sufficient to shift sentiment given persistent softness in primary materials — a note of caution that kept the stock’s gains measured.

The broader market provided a supportive backdrop, with the CAC 40 advancing approximately 1.2% today as European equities built on the post-US midterm election rally, with investors rotating away from technology and toward more cyclical and value-oriented names.

This constructive environment for European industrials and materials stocks helped amplify Arkema’s company-specific catalyst.

Taken together, an earnings release that cleared the bar on the headline EBITDA figure, a steady full-year guidance reaffirmation, and a rising French equity market combined to lift Arkema shares to trade at €59.15 — well above the session open of €58.10 and comfortably above the 52-week low of €48.30, though still meaningfully below the 52-week high of €67.05.